Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Stock Rating Lowered by Wall Street Zen

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday.

Separately, Weiss Ratings began coverage on shares of Inspira Technologies OXY B.H.N. in a research report on Wednesday, May 27th. They set a “sell (e+)” rating for the company. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Inspira Technologies OXY B.H.N. Stock Performance

Shares of Inspira Technologies OXY B.H.N. stock opened at $1.05 on Friday. The company has a current ratio of 1.56, a quick ratio of 1.30 and a debt-to-equity ratio of 0.08. Inspira Technologies OXY B.H.N. has a 52-week low of $0.28 and a 52-week high of $3.85. The business has a 50 day moving average price of $1.49.

Inspira Technologies OXY B.H.N. declared that its Board of Directors has initiated a share repurchase plan on Monday, June 22nd that allows the company to buyback 2,000,000,000,000 outstanding shares. This buyback authorization allows the company to reacquire up to 5.6% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board of directors believes its shares are undervalued.

Inspira Technologies OXY B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.